Bone Density in Voluntary Apheresis Blood Donors

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
A longitudinal, randomized, controlled, single-center Phase IV clinical trial will be performed to assess changes in bone mineral density (BMD) among voluntary apheresis blood donors. The primary outcome measure will be clinically significant decline in BMD at the lumbar spine assessed by dual-energy x-ray absorptiometry (DXA).
Epistemonikos ID: b0abd87a30cc5f1d831c602b2f5c0af67b8934e4
First added on: May 12, 2024